Analysis

  • Is Barack the Cure-All for Pharmaceutical Health?

    Healthcare reform was a key component of Obama's winning campaign, with affordable healthcare coverage its cornerstone. So where exactly do the controversial plans stand with the pharmaceutical sector? Nicola Boyes...

  • From Tree to Treatment

    Pharmaceutical companies are seeking to uncover the next generation of blockbuster products. Nicola Boyes discovers how they are turning to nature for answers.

  • Contracting Out Clinical Trials

    Pharmaceutical companies are facing the prospect of sickly returns, increasing development costs and patent expiries. This has prompted them to turn to resources outside their own research and development capabilities,...

  • A Pharmaceutical Hazard

    The pharmaceutical industry is making headways in responsible disposal of hazardous waste. Are its efforts so far enough to keep the industry and its products safe? Michael Beachey reports.

  • Diabetic Drug Delivery Opens Up

    The global demand for innovative and better diabetes control continues to grow, as the number of sufferers increases. Nicola Boyes analyses the newest forms of drug delivery.

  • Pharming out a New Marketing Message

    Marketing is becoming a bitter pill for pharma companies' advertising departments to swallow. Nicola Boyes takes a look at how some of the industry's biggest players are changing the way...

  • Gaining Microwave Speed

    It takes 24 years from when a compound's potential is discovered until the publication of its clinical effectiveness. Michael Beachey looks at how dedicated microwave instruments may help shorten the...

Close
Close
Close

Go Top